272 related articles for article (PubMed ID: 26971948)
21. Functional consequences of TCF4 missense substitutions associated with Pitt-Hopkins syndrome, mild intellectual disability, and schizophrenia.
Sirp A; Roots K; Nurm K; Tuvikene J; Sepp M; Timmusk T
J Biol Chem; 2021 Dec; 297(6):101381. PubMed ID: 34748727
[TBL] [Abstract][Full Text] [Related]
22. A case of Pitt-Hopkins syndrome with absence of hyperventilation.
Inati A; Abbas HA; Korjian S; Daaboul Y; Harajeily M; Saab R
J Child Neurol; 2013 Dec; 28(12):1698-701. PubMed ID: 23248353
[TBL] [Abstract][Full Text] [Related]
23. Repurposing Approved Drugs as Inhibitors of K
Ekins S; Gerlach J; Zorn KM; Antonio BM; Lin Z; Gerlach A
Pharm Res; 2019 Jul; 36(9):137. PubMed ID: 31332533
[TBL] [Abstract][Full Text] [Related]
24. 263.4 kb deletion within the TCF4 gene consistent with Pitt-Hopkins syndrome, inherited from a mosaic parent with normal phenotype.
Kousoulidou L; Tanteles G; Moutafi M; Sismani C; Patsalis PC; Anastasiadou V
Eur J Med Genet; 2013 Jun; 56(6):314-8. PubMed ID: 23528641
[TBL] [Abstract][Full Text] [Related]
25. Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4.
Bedeschi MF; Marangi G; Calvello MR; Ricciardi S; Leone FPC; Baccarin M; Guerneri S; Orteschi D; Murdolo M; Lattante S; Frangella S; Keena B; Harr MH; Zackai E; Zollino M
Eur J Med Genet; 2017 Nov; 60(11):565-571. PubMed ID: 28807867
[TBL] [Abstract][Full Text] [Related]
26. Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of
Kim H; Gao EB; Draper A; Berens NC; Vihma H; Zhang X; Higashi-Howard A; Ritola KD; Simon JM; Kennedy AJ; Philpot BD
Elife; 2022 May; 11():. PubMed ID: 35535852
[TBL] [Abstract][Full Text] [Related]
27. TCF4, schizophrenia, and Pitt-Hopkins Syndrome.
Blake DJ; Forrest M; Chapman RM; Tinsley CL; O'Donovan MC; Owen MJ
Schizophr Bull; 2010 May; 36(3):443-7. PubMed ID: 20421335
[TBL] [Abstract][Full Text] [Related]
28. Enriched environment ameliorates adult hippocampal neurogenesis deficits in Tcf4 haploinsufficient mice.
Braun K; Häberle BM; Wittmann MT; Lie DC
BMC Neurosci; 2020 Nov; 21(1):50. PubMed ID: 33228529
[TBL] [Abstract][Full Text] [Related]
29. Neurologic and ocular phenotype in Pitt-Hopkins syndrome and a zebrafish model.
Brockschmidt A; Filippi A; Charbel Issa P; Nelles M; Urbach H; Eter N; Driever W; Weber RG
Hum Genet; 2011 Nov; 130(5):645-55. PubMed ID: 21544580
[TBL] [Abstract][Full Text] [Related]
30. The Intellectual Disability and Schizophrenia Associated Transcription Factor TCF4 Is Regulated by Neuronal Activity and Protein Kinase A.
Sepp M; Vihma H; Nurm K; Urb M; Page SC; Roots K; Hark A; Maher BJ; Pruunsild P; Timmusk T
J Neurosci; 2017 Oct; 37(43):10516-10527. PubMed ID: 28951451
[TBL] [Abstract][Full Text] [Related]
31. Molecular and Cellular Function of Transcription Factor 4 in Pitt-Hopkins Syndrome.
Chen HY; Bohlen JF; Maher BJ
Dev Neurosci; 2021; 43(3-4):159-167. PubMed ID: 34134113
[TBL] [Abstract][Full Text] [Related]
32. Transcription factor 4 and its association with psychiatric disorders.
Teixeira JR; Szeto RA; Carvalho VMA; Muotri AR; Papes F
Transl Psychiatry; 2021 Jan; 11(1):19. PubMed ID: 33414364
[TBL] [Abstract][Full Text] [Related]
33. Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome).
Zweier C; Peippo MM; Hoyer J; Sousa S; Bottani A; Clayton-Smith J; Reardon W; Saraiva J; Cabral A; Gohring I; Devriendt K; de Ravel T; Bijlsma EK; Hennekam RC; Orrico A; Cohen M; Dreweke A; Reis A; Nurnberg P; Rauch A
Am J Hum Genet; 2007 May; 80(5):994-1001. PubMed ID: 17436255
[TBL] [Abstract][Full Text] [Related]
34. The basic helix-loop-helix transcription factor TCF4 impacts brain architecture as well as neuronal morphology and differentiation.
Schoof M; Hellwig M; Harrison L; Holdhof D; Lauffer MC; Niesen J; Virdi S; Indenbirken D; Schüller U
Eur J Neurosci; 2020 Jun; 51(11):2219-2235. PubMed ID: 31919899
[TBL] [Abstract][Full Text] [Related]
35. Genotype-phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations.
Rosenfeld JA; Leppig K; Ballif BC; Thiese H; Erdie-Lalena C; Bawle E; Sastry S; Spence JE; Bandholz A; Surti U; Zonana J; Keller K; Meschino W; Bejjani BA; Torchia BS; Shaffer LG
Genet Med; 2009 Nov; 11(11):797-805. PubMed ID: 19938247
[TBL] [Abstract][Full Text] [Related]
36. Various haploinsufficiency mechanisms in Pitt-Hopkins syndrome.
Sparber P; Filatova A; Anisimova I; Markova T; Voinova V; Chuhrova A; Tabakov V; Skoblov M
Eur J Med Genet; 2020 Dec; 63(12):104088. PubMed ID: 33069932
[TBL] [Abstract][Full Text] [Related]
37. A typical variant in TCF4 exon 18 is not associated with Pitt-Hopkins syndrome but with a familial case of mild and nonspecific neurodevelopmental disorder.
Aldeeri AA; Abu-El-Haija A
Am J Med Genet A; 2023 Apr; 191(4):1070-1076. PubMed ID: 36574749
[TBL] [Abstract][Full Text] [Related]
38. Disruption and deletion of the proximal part of TCF4 are associated with mild intellectual disability: About three new patients.
Masson J; Pons L; Busa T; Missirian C; Lines M; Tevissen H; Diguet F; Rollat-Farnier PA; Lesca G; Sanlaville D; Schluth-Bolard C
Eur J Med Genet; 2022 Apr; 65(4):104458. PubMed ID: 35189377
[TBL] [Abstract][Full Text] [Related]
39. Transcription factor 4 and myocyte enhancer factor 2C mutations are not common causes of Rett syndrome.
Armani R; Archer H; Clarke A; Vasudevan P; Zweier C; Ho G; Williamson S; Cloosterman D; Yang N; Christodoulou J
Am J Med Genet A; 2012 Apr; 158A(4):713-9. PubMed ID: 22383159
[TBL] [Abstract][Full Text] [Related]
40. Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.
Quednow BB; Brzózka MM; Rossner MJ
Cell Mol Life Sci; 2014 Aug; 71(15):2815-35. PubMed ID: 24413739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
